NLRP3 and non-small cell lung carcinoma: The well-studied NLRP3 (NLR family pyrin domain-containing 3) inflammasome plays a dominant role in inducing pyroptosis and promoting inflammation, acting as an essential regulator of immune response that can be activated by chemotherapy or radiation treatment in various cancers, including NSCLC [85].